At Fyodor, we’re driven by the power of innovation to solve some of the biggest global health issues of our time. For example, malaria remains one of the single most deadly and wrongly diagnosed global health diseases. The development of the UMT was premised on a simple but fundamental goal, i.e. to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. This avoids individuals taking a drug they did not need, or treating the wrong illness.

The Urine Malaria Test (UMT) is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. It is the product of our ten-year commitment to research and development, collaborating with some of the world’s most prestigious medical research institutions. Wondering if a fever is due to malaria should no longer cause anyone nightmares! This is because it is important to us that anyone with a fever in a malaria-endemic area should be able to test or be tested promptly. Now, with the UMT, it is now possible so they could seek appropriate targeted treatment early. With the UMT, we make malaria testing quick, easy, painless, and fun. The UMT innovation is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. Read about the UMT pivotal clinical trial here